Fr174 TIME TO FIRST DYSPHAGIA SYMPTOM RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION

2021 ◽  
Vol 160 (6) ◽  
pp. S-249-S-250
Author(s):  
Evan S. Dellon ◽  
Margaret H. Collins ◽  
David A. Katzka ◽  
Vincent A. Mukkada ◽  
Gary W. Falk ◽  
...  
Keyword(s):  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Symptom Response ◽  
Post Hoc

Fr175 TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION

2021 ◽  
Vol 160 (6) ◽  
pp. S-250
Author(s):  
Ikuo Hirano ◽  
David A. Katzka ◽  
Margaret H. Collins ◽  
Abigail M. Wojtowicz ◽  
Wenwen Zhang ◽  
...  
Keyword(s):  
Treatment Outcomes ◽  
Eosinophilic Esophagitis ◽  
Oral Suspension ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Post Hoc

scholarly journals Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies

2021 ◽  
Author(s):  
Timo Buhl ◽  
David Rosmarin ◽  
Esther Serra-Baldrich ◽  
Pablo Fernandez-Peñas ◽  
Atsuyuki Igarashi ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Post Hoc

scholarly journals What Does it Mean to be a British Isles Lupus Assessment Group–Based Composite Lupus Assessment Responder? Post Hoc Analysis of 2 Phase 3 Trials

2021 ◽  
Author(s):  
Richard Furie ◽  
Eric F. Morand ◽  
Ian N Bruce ◽  
David Isenberg ◽  
Ronald van Vollenhoven ◽  
...  
Keyword(s):  
British Isles ◽  
Phase 3 ◽  
Post Hoc Analysis ◽  
Post Hoc
Sign in / Sign up

Export Citation Format

Share Document